Sunday 11 October 2026 Export all UHT data to Excel Powerpack

Universal Health Realty Income Trust

UHT Real Estate Reit Healthcare Facilities

Universal Health Realty Income Trust’s revenue for fiscal 2025 (year ended December 2025) was $99.2 million, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 30.3%, free cash flow fell 69.3% and total debt rose 2.73%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years, revenue growth for ten.

37.57 0.03 +0.08%
Market cap
$521.8M
P/E
27.0×
Fwd P/E
31.2×
Dividend yield
7.96%
F-score
4/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Piotroski F-Score
4 7 5 4 5 5 5 5 7 3
P/E ratio
30.63 26.77 39.56 31.42 7.49 45.58 84.43 34.87 22.02 51.25
P/S ratio
5.46 5.19 6.33 7.30 9.72 11.32 20.89 11.05 13.89 13.17
P/FCF ratio
13.46 13.57 22.13 27.22 40.07 43.71 53.13 24.29 32.75 29.91
P/Operating CF
39.86 39.05 57.90 53.87 70.95 77.24 147.57 86.93 81.20 80.43
P/B ratio
3.56 2.86 3.01 2.89 3.48 5.55 8.87 4.24 4.77 4.62
Price to Tangible BV
3.69 2.98 3.16 3.01 3.63 6.00 9.64 4.65 5.29 5.27
EV/Sales
9.17 8.83 10.01 11.00 13.36 15.03 24.35 14.41 17.39 17.81
EV/EBITDA
14.17 13.50 16.04 17.27 19.76 22.50 36.13 21.10 25.68 26.62
EV/Operating CF
18.53 18.65 22.28 21.31 23.56 26.52 44.06 25.59 27.35 29.34
EV/FCF
22.60 23.12 34.97 41.00 55.07 58.03 61.95 31.69 40.99 40.47
Quick Ratio
6.05 8.07 6.54 7.93 8.39 0.82 1.26 1.25 0.98 0.93
Current Ratio
6.05 8.07 6.54 7.93 8.39 0.82 1.26 1.25 0.98 0.93
Net Debt/EBITDA
5.73 5.57 5.89 5.81 5.38 5.55 5.15 4.92 5.16 6.94
Debt/Assets
66.32% 63.40% 60.28% 56.43% 54.94% 59.73% 55.99% 54.01% 52.33% 60.17%
Debt/Equity
2.46 2.05 1.79 1.50 1.40 1.86 1.51 1.32 1.22 1.65
Asset Turnover
0.17 0.17 0.16 0.15 0.15 0.16 0.16 0.16 0.14 0.14
Operating CF/Net income
2.79 2.44 2.79 2.22 0.44 2.27 2.25 1.77 1.01 2.37
Capex/Depreciation
(0.30) (0.32) (0.55) (0.83) (0.97) (0.92) (0.47) (0.33) (0.61) (0.49)
Interest Coverage
1.84 1.95 1.85 2.85 3.28 3.15 2.44 2.68 2.39 2.36
ROE
10.61% 10.11% 7.16% 9.09% 55.37% 11.41% 9.97% 11.83% 22.71% 8.91%
ROA
3.07% 3.27% 2.56% 3.50% 19.99% 3.96% 3.90% 4.97% 8.99% 3.50%
ROIC
4.18% 4.25% 3.55% 3.40% 3.33% 3.62% 3.58% 3.67% 3.24% 2.75%
Return on Tangible Assets
3.64% 3.81% 2.95% 3.90% 20.57% 4.42% 4.35% 5.49% 10.22% 3.86%
Average Days of Receivables
302.29 305.23 318.04 392.43 357.41 50.08 50.15 48.89 45.92 41.42
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.01 0.01 0.02 0.02 0.02 0.02 0.03 0.04 0.04 0.05
Share Based Compensation of Revenue
0.94% 0.86% 0.82% 0.86% 1.12% 1.17% 0.91% 0.75% 0.74% 0.72%
Graham Net Nets
(0.60) (0.61) (0.50) (0.41) (0.32) (0.36) (0.18) (0.32) (0.27) (0.36)
Graham Number
17.82 20.17 19.08 23.93 55.28 19.16 20.34 23.94 34.13 20.23
Earnings Yield
3.26% 3.74% 2.53% 3.18% 13.35% 2.19% 1.18% 2.87% 4.54% 1.95%
Free Cash Flow Yield
7.43% 7.37% 4.52% 3.67% 2.50% 2.29% 1.88% 4.12% 3.05% 3.34%
Revenue per Share
7.18 7.17 6.93 6.58 6.12 5.68 5.62 5.55 5.31 4.98
Operating CF per Share
3.55 3.40 3.11 3.40 3.47 3.22 3.11 3.13 3.38 3.03
Capex per Share
(0.64) (0.66) (1.13) (1.63) (1.99) (1.75) (0.90) (0.60) (1.12) (0.83)
Free Cash Flow per Share
2.91 2.74 1.98 1.77 1.48 1.47 2.21 2.53 2.25 2.19
Cash per Share
0.48 0.51 0.60 0.55 1.64 0.42 0.44 0.37 0.25 0.29
Shareholders Equity per Share
11.03 13.01 14.58 16.64 17.11 11.57 13.23 14.47 15.45 14.21
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
11.03 13.01 14.58 16.64 17.11 11.57 13.23 14.47 15.45 14.21
Free Cash Flow
40.26 37.84 27.36 24.32 20.42 20.21 30.33 34.67 30.69 29.53
Working Capital
74.14 78.76 77.50 91.80 92.44 (3.71) 3.45 3.03 (0.24) (0.89)
Capital Expenditures
(8.84) (9.07) (15.58) (22.48) (27.31) (24.00) (12.32) (8.26) (15.31) (11.20)
Net Current Asset Value
(323.69) (311.43) (303.94) (273.39) (258.15) (318.56) (290.34) (269.90) (266.96) (321.93)
EV/EBIT
26.17 23.77 30.51 32.52 38.95 45.09 72.98 41.13 52.34 54.04
Capex to Sales
0.09 0.09 0.16 0.25 0.32 0.31 0.16 0.11 0.21 0.17
Price to Operating Income
15.59 13.96 19.31 21.59 28.34 33.97 62.59 31.53 41.82 39.94
Other line items
Depreciation/Fixed assets
0.07 0.07 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.05
Cash ROIC
7.54% 6.82% 4.81% 4.20% 3.48% 4.39% 6.57% 7.46% 6.53% 5.78%
Accounts Receivable Turnover
1.20 1.19 1.06 1.01 1.81 7.32 7.42 7.89 8.66 9.57
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days of Inventory on Hand
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
82.47 83.04 90.36 89.94 46.57 10.65 10.41 9.66 8.36 7.01
Average Assets
572.88 588.62 601.95 602.98 546.21 491.40 486.27 486.88 507.38 491.63
Average Common Equity
165.96 190.24 215.02 232.21 197.17 170.37 190.17 204.59 200.92 193.16

Fold the line items

Columns are period end dates